Year|ICCC Group|Age|Event Type|Age-Adjusted Rate|Age-Adjusted CI Lower|Age-Adjusted CI Upper|Count|Population|ICCC.order
1999|All ICCC Groups Combined |0-14|Incidence|145.3|142.1|148.6|7887|54408544|1
1999|All ICCC Groups Combined |0-19|Incidence|157.8|155.0|160.7|11439|72621544|1
1999|I Leukemias, myeloproliferative & myelodysplastic diseases|0-14|Incidence| 45.7| 43.9| 47.5|2481|54408544|2
1999|I Leukemias, myeloproliferative & myelodysplastic diseases|0-19|Incidence| 40.9| 39.5| 42.4|2969|72621544|2
1999|I(a) Lymphoid leukemias|0-14|Incidence| 35.7| 34.1| 37.3|1940|54408544|3
1999|I(a) Lymphoid leukemias|0-19|Incidence| 30.2| 29.0| 31.5|2196|72621544|3
1999|I(b) Acute myeloid leukemias|0-14|Incidence|  7.7|  6.9|  8.4|415|54408544|4
1999|I(b) Acute myeloid leukemias|0-19|Incidence|  8.1|  7.5|  8.8|586|72621544|4
1999|I(c) Chronic myeloproliferative diseases|0-14|Incidence|  0.6|  0.4|  0.8|31|54408544|5
1999|I(c) Chronic myeloproliferative diseases|0-19|Incidence|  1.0|  0.7|  1.2|69|72621544|5
1999|I(d) Myelodysplastic syndrome and other myeloproliferative|0-14|Incidence|~|~|~|~|54408544|6
1999|I(d) Myelodysplastic syndrome and other myeloproliferative|0-19|Incidence|~|~|~|~|72621544|6
1999|I(e) Unspecified and other specified leukemias|0-14|Incidence|  1.6|  1.3|  2.0|87|54408544|7
1999|I(e) Unspecified and other specified leukemias|0-19|Incidence|  1.5|  1.2|  1.8|109|72621544|7
1999|II Lymphomas and reticuloendothelial neoplasms|0-14|Incidence| 15.5| 14.5| 16.6|844|54408544|8
1999|II Lymphomas and reticuloendothelial neoplasms|0-19|Incidence| 23.3| 22.2| 24.5|1692|72621544|8
1999|II(a) Hodgkin lymphomas|0-14|Incidence|  5.5|  4.9|  6.2|300|54408544|9
1999|II(a) Hodgkin lymphomas|0-19|Incidence| 11.8| 11.0| 12.6|857|72621544|9
1999|II(b) Non-Hodgkin lymphomas (except Burkitt lymphoma)|0-14|Incidence|  6.1|  5.4|  6.7|329|54408544|10
1999|II(b) Non-Hodgkin lymphomas (except Burkitt lymphoma)|0-19|Incidence|  7.7|  7.0|  8.3|556|72621544|10
1999|II(c) Burkitt lymphoma|0-14|Incidence|  2.5|  2.1|  3.0|137|54408544|11
1999|II(c) Burkitt lymphoma|0-19|Incidence|  2.4|  2.1|  2.8|177|72621544|11
1999|II(d) Miscellaneous lymphoreticular neoplasms|0-14|Incidence|  1.0|  0.8|  1.3|54|54408544|12
1999|II(d) Miscellaneous lymphoreticular neoplasms|0-19|Incidence|  0.8|  0.6|  1.0|56|72621544|12
1999|II(e) Unspecified lymphomas|0-14|Incidence|  0.4|  0.3|  0.7|24|54408544|13
1999|II(e) Unspecified lymphomas|0-19|Incidence|  0.6|  0.5|  0.8|46|72621544|13
1999|III CNS and misc intracranial and intraspinal neoplasms|0-14|Incidence| 30.7| 29.3| 32.2|1672|54408544|14
1999|III CNS and misc intracranial and intraspinal neoplasms|0-19|Incidence| 27.8| 26.6| 29.0|2018|72621544|14
1999|III(a) Ependymomas and choroid plexus tumor|0-14|Incidence|  2.8|  2.4|  3.3|152|54408544|15
1999|III(a) Ependymomas and choroid plexus tumor|0-19|Incidence|  2.5|  2.1|  2.9|180|72621544|15
1999|III(b) Astrocytomas|0-14|Incidence| 13.5| 12.6| 14.6|737|54408544|16
1999|III(b) Astrocytomas|0-19|Incidence| 12.8| 12.0| 13.7|933|72621544|16
1999|III(c) Intracranial and intraspinal embryonal tumors|0-14|Incidence|  7.9|  7.2|  8.7|432|54408544|17
1999|III(c) Intracranial and intraspinal embryonal tumors|0-19|Incidence|  6.7|  6.1|  7.3|484|72621544|17
1999|III(d) Other gliomas|0-14|Incidence|  5.3|  4.7|  5.9|287|54408544|18
1999|III(d) Other gliomas|0-19|Incidence|  4.7|  4.2|  5.2|343|72621544|18
1999|III(e) Other specified intracranial/intraspinal neoplasms|0-14|Incidence|  0.5|  0.3|  0.7|25|54408544|19
1999|III(e) Other specified intracranial/intraspinal neoplasms|0-19|Incidence|  0.5|  0.3|  0.6|33|72621544|19
1999|III(f) Unspecified intracranial and intraspinal neoplasms|0-14|Incidence|  0.7|  0.5|  1.0|39|54408544|20
1999|III(f) Unspecified intracranial and intraspinal neoplasms|0-19|Incidence|  0.6|  0.5|  0.8|45|72621544|20
1999|IV Neuroblastoma and other peripheral nervous cell tumors|0-14|Incidence| 10.6|  9.7| 11.5|569|54408544|21
1999|IV Neuroblastoma and other peripheral nervous cell tumors|0-19|Incidence|  8.2|  7.5|  8.9|588|72621544|21
1999|IV(a) Neuroblastoma and ganglioneuroblastoma|0-14|Incidence| 10.4|  9.6| 11.3|561|54408544|22
1999|IV(a) Neuroblastoma and ganglioneuroblastoma|0-19|Incidence|  7.9|  7.3|  8.6|569|72621544|22
1999|IV(b) Other peripheral nervous cell tumors|0-14|Incidence|~|~|~|~|54408544|23
1999|IV(b) Other peripheral nervous cell tumors|0-19|Incidence|  0.3|  0.2|  0.4|19|72621544|23
1999|V Retinoblastoma|0-14|Incidence|  4.3|  3.7|  4.9|230|54408544|24
1999|V Retinoblastoma|0-19|Incidence|  3.2|  2.8|  3.7|231|72621544|24
1999|VI Renal tumors|0-14|Incidence|  8.1|  7.4|  8.9|439|54408544|25
1999|VI Renal tumors|0-19|Incidence|  6.4|  5.8|  7.0|465|72621544|25
1999|VI(a) Nephroblastoma and other nonepithelial renal tumors|0-14|Incidence|  7.6|  6.9|  8.4|413|54408544|26
1999|VI(a) Nephroblastoma and other nonepithelial renal tumors|0-19|Incidence|  5.8|  5.3|  6.4|421|72621544|26
1999|VI(b) Renal carcinomas|0-14|Incidence|  0.4|  0.3|  0.6|23|54408544|27
1999|VI(b) Renal carcinomas|0-19|Incidence|  0.6|  0.4|  0.8|40|72621544|27
1999|VI(c) Unspecified malignant renal tumors|0-14|Incidence|~|~|~|~|54408544|28
1999|VI(c) Unspecified malignant renal tumors|0-19|Incidence|~|~|~|~|72621544|28
1999|VII Hepatic tumors|0-14|Incidence|  2.1|  1.7|  2.5|113|54408544|29
1999|VII Hepatic tumors|0-19|Incidence|  2.0|  1.7|  2.3|143|72621544|29
1999|VII(a) Hepatoblastoma|0-14|Incidence|  1.7|  1.4|  2.1|91|54408544|30
1999|VII(a) Hepatoblastoma|0-19|Incidence|  1.3|  1.0|  1.6|91|72621544|30
1999|VII(b) Hepatic carcinomas|0-14|Incidence|  0.4|  0.3|  0.6|22|54408544|31
1999|VII(b) Hepatic carcinomas|0-19|Incidence|  0.7|  0.5|  0.9|51|72621544|31
1999|VII(c) Unspecified malignant hepatic tumors|0-14|Incidence|~|~|~|~|54408544|32
1999|VII(c) Unspecified malignant hepatic tumors|0-19|Incidence|~|~|~|~|72621544|32
1999|VIII Malignant bone tumors|0-14|Incidence|  7.3|  6.6|  8.0|395|54408544|33
1999|VIII Malignant bone tumors|0-19|Incidence|  8.8|  8.2|  9.5|640|72621544|33
1999|VIII(a) Osteosarcomas|0-14|Incidence|  4.3|  3.7|  4.8|231|54408544|34
1999|VIII(a) Osteosarcomas|0-19|Incidence|  5.1|  4.6|  5.7|370|72621544|34
1999|VIII(b) Chondrosarcomas|0-14|Incidence|~|~|~|~|54408544|35
1999|VIII(b) Chondrosarcomas|0-19|Incidence|  0.4|  0.2|  0.5|27|72621544|35
1999|VIII(c) Ewing tumor and related sarcomas of bone|0-14|Incidence|  2.4|  2.0|  2.8|130|54408544|36
1999|VIII(c) Ewing tumor and related sarcomas of bone|0-19|Incidence|  2.7|  2.3|  3.1|197|72621544|36
1999|VIII(d) Other specified malignant bone tumors|0-14|Incidence|  0.3|  0.2|  0.5|18|54408544|37
1999|VIII(d) Other specified malignant bone tumors|0-19|Incidence|  0.5|  0.3|  0.7|35|72621544|37
1999|VIII(e) Unspecified malignant bone tumors|0-14|Incidence|~|~|~|~|54408544|38
1999|VIII(e) Unspecified malignant bone tumors|0-19|Incidence|~|~|~|~|72621544|38
1999|IX Soft tissue and other extraosseous sarcomas|0-14|Incidence|  9.4|  8.6| 10.3|513|54408544|39
1999|IX Soft tissue and other extraosseous sarcomas|0-19|Incidence| 10.7| 10.0| 11.5|776|72621544|39
1999|IX(a) Rhabdomyosarcomas|0-14|Incidence|  4.9|  4.3|  5.5|265|54408544|40
1999|IX(a) Rhabdomyosarcomas|0-19|Incidence|  4.5|  4.0|  5.0|326|72621544|40
1999|IX(b) Fibrosarcomas, peripheral nerve & other fibrous|0-14|Incidence|  1.0|  0.7|  1.3|52|54408544|41
1999|IX(b) Fibrosarcomas, peripheral nerve & other fibrous|0-19|Incidence|  1.1|  0.9|  1.4|81|72621544|41
1999|IX(c) Kaposi sarcoma|0-14|Incidence|~|~|~|~|54408544|42
1999|IX(c) Kaposi sarcoma|0-19|Incidence|~|~|~|~|72621544|42
1999|IX(d) Other specified soft tissue sarcomas|0-14|Incidence|  2.6|  2.2|  3.1|143|54408544|43
1999|IX(d) Other specified soft tissue sarcomas|0-19|Incidence|  3.8|  3.4|  4.3|277|72621544|43
1999|IX(e) Unspecified soft tissue sarcomas|0-14|Incidence|  1.0|  0.7|  1.3|52|54408544|44
1999|IX(e) Unspecified soft tissue sarcomas|0-19|Incidence|  1.2|  1.0|  1.5|89|72621544|44
1999|X Germ cell & trophoblastic tumors & neoplasms of gonads|0-14|Incidence|  5.0|  4.4|  5.6|269|54408544|45
1999|X Germ cell & trophoblastic tumors & neoplasms of gonads|0-19|Incidence| 10.1|  9.4| 10.9|732|72621544|45
1999|X(a) Intracranial & intraspinal germ cell tumors|0-14|Incidence|  1.3|  1.1|  1.7|73|54408544|46
1999|X(a) Intracranial & intraspinal germ cell tumors|0-19|Incidence|  1.4|  1.2|  1.7|104|72621544|46
1999|X(b) Extracranial & extragonadal germ cell tumors|0-14|Incidence|  1.4|  1.1|  1.7|73|54408544|47
1999|X(b) Extracranial & extragonadal germ cell tumors|0-19|Incidence|  1.3|  1.1|  1.6|97|72621544|47
1999|X(c) Malignant gonadal germ cell tumors|0-14|Incidence|  2.1|  1.7|  2.5|111|54408544|48
1999|X(c) Malignant gonadal germ cell tumors|0-19|Incidence|  6.7|  6.1|  7.3|483|72621544|48
1999|X(d) Gonadal carcinomas|0-14|Incidence|~|~|~|~|54408544|49
1999|X(d) Gonadal carcinomas|0-19|Incidence|  0.4|  0.3|  0.6|31|72621544|49
1999|X(e) Other and unspecified malignant gonadal tumors|0-14|Incidence|~|~|~|~|54408544|50
1999|X(e) Other and unspecified malignant gonadal tumors|0-19|Incidence|  0.2|  0.1|  0.4|17|72621544|50
1999|XI Other malignant epithelial neoplasms and melanomas|0-14|Incidence|  5.9|  5.2|  6.6|318|54408544|51
1999|XI Other malignant epithelial neoplasms and melanomas|0-19|Incidence| 15.3| 14.4| 16.2|1107|72621544|51
1999|XI(a) Adrenocortical carcinomas|0-14|Incidence|~|~|~|~|54408544|52
1999|XI(a) Adrenocortical carcinomas|0-19|Incidence|  0.2|  0.1|  0.4|16|72621544|52
1999|XI(b) Thyroid carcinomas|0-14|Incidence|  1.9|  1.5|  2.3|101|54408544|53
1999|XI(b) Thyroid carcinomas|0-19|Incidence|  5.8|  5.2|  6.3|418|72621544|53
1999|XI(c) Nasopharyngeal carcinomas|0-14|Incidence|  0.4|  0.2|  0.6|21|54408544|54
1999|XI(c) Nasopharyngeal carcinomas|0-19|Incidence|  0.6|  0.4|  0.8|41|72621544|54
1999|XI(d) Malignant melanomas|0-14|Incidence|  1.7|  1.4|  2.1|91|54408544|55
1999|XI(d) Malignant melanomas|0-19|Incidence|  4.6|  4.1|  5.1|334|72621544|55
1999|XI(e) Skin carcinomas|0-14|Incidence|~|~|~|~|54408544|56
1999|XI(e) Skin carcinomas|0-19|Incidence|~|~|~|~|72621544|56
1999|XI(f) Other and unspecified carcinomas|0-14|Incidence|  1.7|  1.3|  2.0|90|54408544|57
1999|XI(f) Other and unspecified carcinomas|0-19|Incidence|  4.0|  3.6|  4.5|292|72621544|57
1999|XII Other and unspecified malignant neoplasms|0-14|Incidence|  0.5|  0.3|  0.7|27|54408544|58
1999|XII Other and unspecified malignant neoplasms|0-19|Incidence|  0.7|  0.6|  1.0|54|72621544|58
1999|XII(a) Other specified malignant tumors|0-14|Incidence|~|~|~|~|54408544|59
1999|XII(a) Other specified malignant tumors|0-19|Incidence|~|~|~|~|72621544|59
1999|XII(b) Other unspecified malignant tumors|0-14|Incidence|  0.3|  0.2|  0.5|18|54408544|60
1999|XII(b) Other unspecified malignant tumors|0-19|Incidence|  0.6|  0.4|  0.8|40|72621544|60
1999|Not classified by ICCC|0-14|Incidence|  0.3|  0.2|  0.5|17|54408544|61
1999|Not classified by ICCC|0-19|Incidence|  0.3|  0.2|  0.5|24|72621544|61
2000|All ICCC Groups Combined |0-14|Incidence|147.4|144.3|150.7|8087|54979517|1
2000|All ICCC Groups Combined |0-19|Incidence|161.4|158.6|164.4|11832|73418994|1
2000|I Leukemias, myeloproliferative & myelodysplastic diseases|0-14|Incidence| 45.7| 43.9| 47.5|2501|54979517|2
2000|I Leukemias, myeloproliferative & myelodysplastic diseases|0-19|Incidence| 41.0| 39.5| 42.5|2998|73418994|2
2000|I(a) Lymphoid leukemias|0-14|Incidence| 36.7| 35.1| 38.4|2010|54979517|3
2000|I(a) Lymphoid leukemias|0-19|Incidence| 31.4| 30.2| 32.7|2299|73418994|3
2000|I(b) Acute myeloid leukemias|0-14|Incidence|  6.6|  5.9|  7.3|360|54979517|4
2000|I(b) Acute myeloid leukemias|0-19|Incidence|  7.1|  6.5|  7.7|517|73418994|4
2000|I(c) Chronic myeloproliferative diseases|0-14|Incidence|  0.7|  0.5|  1.0|41|54979517|5
2000|I(c) Chronic myeloproliferative diseases|0-19|Incidence|  0.9|  0.7|  1.1|63|73418994|5
2000|I(d) Myelodysplastic syndrome and other myeloproliferative|0-14|Incidence|~|~|~|~|54979517|6
2000|I(d) Myelodysplastic syndrome and other myeloproliferative|0-19|Incidence|~|~|~|~|73418994|6
2000|I(e) Unspecified and other specified leukemias|0-14|Incidence|  1.5|  1.2|  1.9|84|54979517|7
2000|I(e) Unspecified and other specified leukemias|0-19|Incidence|  1.5|  1.3|  1.8|112|73418994|7
2000|II Lymphomas and reticuloendothelial neoplasms|0-14|Incidence| 16.5| 15.4| 17.6|909|54979517|8
2000|II Lymphomas and reticuloendothelial neoplasms|0-19|Incidence| 24.7| 23.6| 25.8|1813|73418994|8
2000|II(a) Hodgkin lymphomas|0-14|Incidence|  5.9|  5.3|  6.6|325|54979517|9
2000|II(a) Hodgkin lymphomas|0-19|Incidence| 12.3| 11.5| 13.1|902|73418994|9
2000|II(b) Non-Hodgkin lymphomas (except Burkitt lymphoma)|0-14|Incidence|  5.9|  5.3|  6.6|325|54979517|10
2000|II(b) Non-Hodgkin lymphomas (except Burkitt lymphoma)|0-19|Incidence|  8.1|  7.4|  8.7|592|73418994|10
2000|II(c) Burkitt lymphoma|0-14|Incidence|  2.7|  2.3|  3.2|150|54979517|11
2000|II(c) Burkitt lymphoma|0-19|Incidence|  2.6|  2.3|  3.0|192|73418994|11
2000|II(d) Miscellaneous lymphoreticular neoplasms|0-14|Incidence|  1.3|  1.0|  1.6|71|54979517|12
2000|II(d) Miscellaneous lymphoreticular neoplasms|0-19|Incidence|  1.0|  0.8|  1.3|74|73418994|12
2000|II(e) Unspecified lymphomas|0-14|Incidence|  0.7|  0.5|  0.9|38|54979517|13
2000|II(e) Unspecified lymphomas|0-19|Incidence|  0.7|  0.5|  0.9|53|73418994|13
2000|III CNS and misc intracranial and intraspinal neoplasms|0-14|Incidence| 31.7| 30.2| 33.2|1740|54979517|14
2000|III CNS and misc intracranial and intraspinal neoplasms|0-19|Incidence| 29.0| 27.8| 30.3|2130|73418994|14
2000|III(a) Ependymomas and choroid plexus tumor|0-14|Incidence|  2.7|  2.3|  3.1|146|54979517|15
2000|III(a) Ependymomas and choroid plexus tumor|0-19|Incidence|  2.3|  2.0|  2.7|170|73418994|15
2000|III(b) Astrocytomas|0-14|Incidence| 15.9| 14.9| 17.0|873|54979517|16
2000|III(b) Astrocytomas|0-19|Incidence| 14.8| 13.9| 15.7|1084|73418994|16
2000|III(c) Intracranial and intraspinal embryonal tumors|0-14|Incidence|  7.5|  6.8|  8.3|413|54979517|17
2000|III(c) Intracranial and intraspinal embryonal tumors|0-19|Incidence|  6.5|  5.9|  7.1|478|73418994|17
2000|III(d) Other gliomas|0-14|Incidence|  4.4|  3.9|  5.0|242|54979517|18
2000|III(d) Other gliomas|0-19|Incidence|  4.2|  3.8|  4.7|311|73418994|18
2000|III(e) Other specified intracranial/intraspinal neoplasms|0-14|Incidence|  0.5|  0.3|  0.7|28|54979517|19
2000|III(e) Other specified intracranial/intraspinal neoplasms|0-19|Incidence|  0.5|  0.4|  0.7|37|73418994|19
2000|III(f) Unspecified intracranial and intraspinal neoplasms|0-14|Incidence|  0.7|  0.5|  1.0|38|54979517|20
2000|III(f) Unspecified intracranial and intraspinal neoplasms|0-19|Incidence|  0.7|  0.5|  0.9|50|73418994|20
2000|IV Neuroblastoma and other peripheral nervous cell tumors|0-14|Incidence| 10.1|  9.2| 10.9|549|54979517|21
2000|IV Neuroblastoma and other peripheral nervous cell tumors|0-19|Incidence|  7.6|  7.0|  8.3|557|73418994|21
2000|IV(a) Neuroblastoma and ganglioneuroblastoma|0-14|Incidence| 10.0|  9.2| 10.9|544|54979517|22
2000|IV(a) Neuroblastoma and ganglioneuroblastoma|0-19|Incidence|  7.5|  6.9|  8.2|550|73418994|22
2000|IV(b) Other peripheral nervous cell tumors|0-14|Incidence|~|~|~|~|54979517|23
2000|IV(b) Other peripheral nervous cell tumors|0-19|Incidence|~|~|~|~|73418994|23
2000|V Retinoblastoma|0-14|Incidence|  4.3|  3.7|  4.9|233|54979517|24
2000|V Retinoblastoma|0-19|Incidence|  3.2|  2.8|  3.7|234|73418994|24
2000|VI Renal tumors|0-14|Incidence|  8.7|  7.9|  9.5|473|54979517|25
2000|VI Renal tumors|0-19|Incidence|  6.8|  6.2|  7.4|493|73418994|25
2000|VI(a) Nephroblastoma and other nonepithelial renal tumors|0-14|Incidence|  8.3|  7.6|  9.1|454|54979517|26
2000|VI(a) Nephroblastoma and other nonepithelial renal tumors|0-19|Incidence|  6.3|  5.7|  6.9|458|73418994|26
2000|VI(b) Renal carcinomas|0-14|Incidence|  0.3|  0.2|  0.5|18|54979517|27
2000|VI(b) Renal carcinomas|0-19|Incidence|  0.5|  0.3|  0.6|34|73418994|27
2000|VI(c) Unspecified malignant renal tumors|0-14|Incidence|~|~|~|~|54979517|28
2000|VI(c) Unspecified malignant renal tumors|0-19|Incidence|~|~|~|~|73418994|28
2000|VII Hepatic tumors|0-14|Incidence|  2.3|  1.9|  2.7|123|54979517|29
2000|VII Hepatic tumors|0-19|Incidence|  1.9|  1.6|  2.2|138|73418994|29
2000|VII(a) Hepatoblastoma|0-14|Incidence|  2.0|  1.7|  2.4|110|54979517|30
2000|VII(a) Hepatoblastoma|0-19|Incidence|  1.5|  1.2|  1.8|110|73418994|30
2000|VII(b) Hepatic carcinomas|0-14|Incidence|~|~|~|~|54979517|31
2000|VII(b) Hepatic carcinomas|0-19|Incidence|  0.4|  0.3|  0.6|28|73418994|31
2000|VII(c) Unspecified malignant hepatic tumors|0-14|Incidence|~|~|~|~|54979517|32
2000|VII(c) Unspecified malignant hepatic tumors|0-19|Incidence|~|~|~|~|73418994|32
2000|VIII Malignant bone tumors|0-14|Incidence|  6.6|  5.9|  7.3|363|54979517|33
2000|VIII Malignant bone tumors|0-19|Incidence|  8.4|  7.7|  9.1|617|73418994|33
2000|VIII(a) Osteosarcomas|0-14|Incidence|  3.6|  3.2|  4.2|201|54979517|34
2000|VIII(a) Osteosarcomas|0-19|Incidence|  4.7|  4.3|  5.3|349|73418994|34
2000|VIII(b) Chondrosarcomas|0-14|Incidence|~|~|~|~|54979517|35
2000|VIII(b) Chondrosarcomas|0-19|Incidence|~|~|~|~|73418994|35
2000|VIII(c) Ewing tumor and related sarcomas of bone|0-14|Incidence|  2.6|  2.2|  3.1|145|54979517|36
2000|VIII(c) Ewing tumor and related sarcomas of bone|0-19|Incidence|  3.0|  2.6|  3.5|223|73418994|36
2000|VIII(d) Other specified malignant bone tumors|0-14|Incidence|~|~|~|~|54979517|37
2000|VIII(d) Other specified malignant bone tumors|0-19|Incidence|  0.2|  0.1|  0.4|16|73418994|37
2000|VIII(e) Unspecified malignant bone tumors|0-14|Incidence|~|~|~|~|54979517|38
2000|VIII(e) Unspecified malignant bone tumors|0-19|Incidence|  0.2|  0.1|  0.4|17|73418994|38
2000|IX Soft tissue and other extraosseous sarcomas|0-14|Incidence| 10.4|  9.6| 11.3|571|54979517|39
2000|IX Soft tissue and other extraosseous sarcomas|0-19|Incidence| 11.9| 11.1| 12.7|872|73418994|39
2000|IX(a) Rhabdomyosarcomas|0-14|Incidence|  5.3|  4.7|  5.9|290|54979517|40
2000|IX(a) Rhabdomyosarcomas|0-19|Incidence|  4.9|  4.4|  5.4|358|73418994|40
2000|IX(b) Fibrosarcomas, peripheral nerve & other fibrous|0-14|Incidence|  0.9|  0.7|  1.2|52|54979517|41
2000|IX(b) Fibrosarcomas, peripheral nerve & other fibrous|0-19|Incidence|  1.2|  1.0|  1.5|88|73418994|41
2000|IX(c) Kaposi sarcoma|0-14|Incidence|~|~|~|~|54979517|42
2000|IX(c) Kaposi sarcoma|0-19|Incidence|~|~|~|~|73418994|42
2000|IX(d) Other specified soft tissue sarcomas|0-14|Incidence|  3.1|  2.6|  3.6|170|54979517|43
2000|IX(d) Other specified soft tissue sarcomas|0-19|Incidence|  4.4|  3.9|  4.9|323|73418994|43
2000|IX(e) Unspecified soft tissue sarcomas|0-14|Incidence|  1.1|  0.8|  1.4|58|54979517|44
2000|IX(e) Unspecified soft tissue sarcomas|0-19|Incidence|  1.4|  1.1|  1.7|100|73418994|44
2000|X Germ cell & trophoblastic tumors & neoplasms of gonads|0-14|Incidence|  4.9|  4.3|  5.5|270|54979517|45
2000|X Germ cell & trophoblastic tumors & neoplasms of gonads|0-19|Incidence| 10.7| 10.0| 11.5|784|73418994|45
2000|X(a) Intracranial & intraspinal germ cell tumors|0-14|Incidence|  1.4|  1.1|  1.8|79|54979517|46
2000|X(a) Intracranial & intraspinal germ cell tumors|0-19|Incidence|  1.7|  1.4|  2.0|122|73418994|46
2000|X(b) Extracranial & extragonadal germ cell tumors|0-14|Incidence|  1.1|  0.9|  1.4|61|54979517|47
2000|X(b) Extracranial & extragonadal germ cell tumors|0-19|Incidence|  1.4|  1.1|  1.7|102|73418994|47
2000|X(c) Malignant gonadal germ cell tumors|0-14|Incidence|  2.2|  1.8|  2.6|119|54979517|48
2000|X(c) Malignant gonadal germ cell tumors|0-19|Incidence|  6.9|  6.3|  7.6|508|73418994|48
2000|X(d) Gonadal carcinomas|0-14|Incidence|~|~|~|~|54979517|49
2000|X(d) Gonadal carcinomas|0-19|Incidence|  0.5|  0.4|  0.7|37|73418994|49
2000|X(e) Other and unspecified malignant gonadal tumors|0-14|Incidence|~|~|~|~|54979517|50
2000|X(e) Other and unspecified malignant gonadal tumors|0-19|Incidence|~|~|~|~|73418994|50
2000|XI Other malignant epithelial neoplasms and melanomas|0-14|Incidence|  5.5|  4.9|  6.2|305|54979517|51
2000|XI Other malignant epithelial neoplasms and melanomas|0-19|Incidence| 15.4| 14.5| 16.3|1128|73418994|51
2000|XI(a) Adrenocortical carcinomas|0-14|Incidence|~|~|~|~|54979517|52
2000|XI(a) Adrenocortical carcinomas|0-19|Incidence|  0.3|  0.2|  0.4|21|73418994|52
2000|XI(b) Thyroid carcinomas|0-14|Incidence|  1.8|  1.5|  2.2|101|54979517|53
2000|XI(b) Thyroid carcinomas|0-19|Incidence|  5.7|  5.2|  6.3|418|73418994|53
2000|XI(c) Nasopharyngeal carcinomas|0-14|Incidence|  0.3|  0.2|  0.5|19|54979517|54
2000|XI(c) Nasopharyngeal carcinomas|0-19|Incidence|  0.5|  0.4|  0.7|39|73418994|54
2000|XI(d) Malignant melanomas|0-14|Incidence|  1.6|  1.3|  2.0|89|54979517|55
2000|XI(d) Malignant melanomas|0-19|Incidence|  4.9|  4.4|  5.5|361|73418994|55
2000|XI(e) Skin carcinomas|0-14|Incidence|~|~|~|~|54979517|56
2000|XI(e) Skin carcinomas|0-19|Incidence|~|~|~|~|73418994|56
2000|XI(f) Other and unspecified carcinomas|0-14|Incidence|  1.4|  1.1|  1.8|79|54979517|57
2000|XI(f) Other and unspecified carcinomas|0-19|Incidence|  3.9|  3.4|  4.3|283|73418994|57
2000|XII Other and unspecified malignant neoplasms|0-14|Incidence|  0.6|  0.4|  0.9|35|54979517|58
2000|XII Other and unspecified malignant neoplasms|0-19|Incidence|  0.7|  0.5|  0.9|49|73418994|58
2000|XII(a) Other specified malignant tumors|0-14|Incidence|~|~|~|~|54979517|59
2000|XII(a) Other specified malignant tumors|0-19|Incidence|~|~|~|~|73418994|59
2000|XII(b) Other unspecified malignant tumors|0-14|Incidence|  0.4|  0.3|  0.6|22|54979517|60
2000|XII(b) Other unspecified malignant tumors|0-19|Incidence|  0.5|  0.3|  0.6|34|73418994|60
2000|Not classified by ICCC|0-14|Incidence|~|~|~|~|54979517|61
2000|Not classified by ICCC|0-19|Incidence|  0.3|  0.2|  0.4|19|73418994|61
2001|All ICCC Groups Combined |0-14|Incidence|154.9|151.6|158.2|8649|55859601|1
2001|All ICCC Groups Combined |0-19|Incidence|168.9|166.0|171.9|12593|74580361|1
2001|I Leukemias, myeloproliferative & myelodysplastic diseases|0-14|Incidence| 50.4| 48.5| 52.3|2801|55859601|2
2001|I Leukemias, myeloproliferative & myelodysplastic diseases|0-19|Incidence| 45.4| 43.8| 46.9|3371|74580361|2
2001|I(a) Lymphoid leukemias|0-14|Incidence| 38.7| 37.1| 40.4|2147|55859601|3
2001|I(a) Lymphoid leukemias|0-19|Incidence| 33.0| 31.7| 34.3|2446|74580361|3
2001|I(b) Acute myeloid leukemias|0-14|Incidence|  7.3|  6.6|  8.1|410|55859601|4
2001|I(b) Acute myeloid leukemias|0-19|Incidence|  7.7|  7.1|  8.4|575|74580361|4
2001|I(c) Chronic myeloproliferative diseases|0-14|Incidence|  1.6|  1.3|  2.0|90|55859601|5
2001|I(c) Chronic myeloproliferative diseases|0-19|Incidence|  2.0|  1.7|  2.4|152|74580361|5
2001|I(d) Myelodysplastic syndrome and other myeloproliferative|0-14|Incidence|  1.6|  1.3|  2.0|90|55859601|6
2001|I(d) Myelodysplastic syndrome and other myeloproliferative|0-19|Incidence|  1.5|  1.2|  1.8|109|74580361|6
2001|I(e) Unspecified and other specified leukemias|0-14|Incidence|  1.1|  0.9|  1.5|64|55859601|7
2001|I(e) Unspecified and other specified leukemias|0-19|Incidence|  1.2|  1.0|  1.5|89|74580361|7
2001|II Lymphomas and reticuloendothelial neoplasms|0-14|Incidence| 16.0| 15.0| 17.1|898|55859601|8
2001|II Lymphomas and reticuloendothelial neoplasms|0-19|Incidence| 24.7| 23.6| 25.9|1844|74580361|8
2001|II(a) Hodgkin lymphomas|0-14|Incidence|  5.8|  5.2|  6.5|329|55859601|9
2001|II(a) Hodgkin lymphomas|0-19|Incidence| 12.6| 11.8| 13.4|940|74580361|9
2001|II(b) Non-Hodgkin lymphomas (except Burkitt lymphoma)|0-14|Incidence|  6.7|  6.0|  7.4|374|55859601|10
2001|II(b) Non-Hodgkin lymphomas (except Burkitt lymphoma)|0-19|Incidence|  8.8|  8.2|  9.5|660|74580361|10
2001|II(c) Burkitt lymphoma|0-14|Incidence|  2.3|  1.9|  2.7|127|55859601|11
2001|II(c) Burkitt lymphoma|0-19|Incidence|  2.2|  1.9|  2.5|162|74580361|11
2001|II(d) Miscellaneous lymphoreticular neoplasms|0-14|Incidence|  0.9|  0.7|  1.2|51|55859601|12
2001|II(d) Miscellaneous lymphoreticular neoplasms|0-19|Incidence|  0.7|  0.5|  0.9|52|74580361|12
2001|II(e) Unspecified lymphomas|0-14|Incidence|  0.3|  0.2|  0.5|17|55859601|13
2001|II(e) Unspecified lymphomas|0-19|Incidence|  0.4|  0.3|  0.6|30|74580361|13
2001|III CNS and misc intracranial and intraspinal neoplasms|0-14|Incidence| 31.8| 30.3| 33.3|1773|55859601|14
2001|III CNS and misc intracranial and intraspinal neoplasms|0-19|Incidence| 29.2| 28.0| 30.4|2174|74580361|14
2001|III(a) Ependymomas and choroid plexus tumor|0-14|Incidence|  2.7|  2.3|  3.2|150|55859601|15
2001|III(a) Ependymomas and choroid plexus tumor|0-19|Incidence|  2.3|  2.0|  2.7|174|74580361|15
2001|III(b) Astrocytomas|0-14|Incidence| 15.6| 14.6| 16.7|872|55859601|16
2001|III(b) Astrocytomas|0-19|Incidence| 14.4| 13.6| 15.3|1076|74580361|16
2001|III(c) Intracranial and intraspinal embryonal tumors|0-14|Incidence|  7.2|  6.5|  8.0|402|55859601|17
2001|III(c) Intracranial and intraspinal embryonal tumors|0-19|Incidence|  6.5|  6.0|  7.2|487|74580361|17
2001|III(d) Other gliomas|0-14|Incidence|  5.2|  4.6|  5.8|291|55859601|18
2001|III(d) Other gliomas|0-19|Incidence|  4.9|  4.4|  5.4|364|74580361|18
2001|III(e) Other specified intracranial/intraspinal neoplasms|0-14|Incidence|  0.7|  0.5|  0.9|37|55859601|19
2001|III(e) Other specified intracranial/intraspinal neoplasms|0-19|Incidence|  0.6|  0.4|  0.8|44|74580361|19
2001|III(f) Unspecified intracranial and intraspinal neoplasms|0-14|Incidence|  0.4|  0.2|  0.6|21|55859601|20
2001|III(f) Unspecified intracranial and intraspinal neoplasms|0-19|Incidence|  0.4|  0.3|  0.6|29|74580361|20
2001|IV Neuroblastoma and other peripheral nervous cell tumors|0-14|Incidence| 11.5| 10.6| 12.4|644|55859601|21
2001|IV Neuroblastoma and other peripheral nervous cell tumors|0-19|Incidence|  8.8|  8.1|  9.5|656|74580361|21
2001|IV(a) Neuroblastoma and ganglioneuroblastoma|0-14|Incidence| 11.4| 10.5| 12.3|639|55859601|22
2001|IV(a) Neuroblastoma and ganglioneuroblastoma|0-19|Incidence|  8.6|  8.0|  9.3|646|74580361|22
2001|IV(b) Other peripheral nervous cell tumors|0-14|Incidence|~|~|~|~|55859601|23
2001|IV(b) Other peripheral nervous cell tumors|0-19|Incidence|~|~|~|~|74580361|23
2001|V Retinoblastoma|0-14|Incidence|  4.3|  3.8|  4.9|242|55859601|24
2001|V Retinoblastoma|0-19|Incidence|  3.2|  2.8|  3.7|242|74580361|24
2001|VI Renal tumors|0-14|Incidence|  8.6|  7.8|  9.4|475|55859601|25
2001|VI Renal tumors|0-19|Incidence|  6.7|  6.2|  7.4|500|74580361|25
2001|VI(a) Nephroblastoma and other nonepithelial renal tumors|0-14|Incidence|  8.2|  7.4|  9.0|453|55859601|26
2001|VI(a) Nephroblastoma and other nonepithelial renal tumors|0-19|Incidence|  6.2|  5.6|  6.7|456|74580361|26
2001|VI(b) Renal carcinomas|0-14|Incidence|  0.4|  0.2|  0.5|20|55859601|27
2001|VI(b) Renal carcinomas|0-19|Incidence|  0.6|  0.4|  0.8|42|74580361|27
2001|VI(c) Unspecified malignant renal tumors|0-14|Incidence|~|~|~|~|55859601|28
2001|VI(c) Unspecified malignant renal tumors|0-19|Incidence|~|~|~|~|74580361|28
2001|VII Hepatic tumors|0-14|Incidence|  2.1|  1.7|  2.5|118|55859601|29
2001|VII Hepatic tumors|0-19|Incidence|  1.8|  1.5|  2.2|137|74580361|29
2001|VII(a) Hepatoblastoma|0-14|Incidence|  1.7|  1.4|  2.1|95|55859601|30
2001|VII(a) Hepatoblastoma|0-19|Incidence|  1.3|  1.0|  1.6|96|74580361|30
2001|VII(b) Hepatic carcinomas|0-14|Incidence|  0.4|  0.2|  0.6|22|55859601|31
2001|VII(b) Hepatic carcinomas|0-19|Incidence|  0.5|  0.4|  0.7|40|74580361|31
2001|VII(c) Unspecified malignant hepatic tumors|0-14|Incidence|~|~|~|~|55859601|32
2001|VII(c) Unspecified malignant hepatic tumors|0-19|Incidence|~|~|~|~|74580361|32
2001|VIII Malignant bone tumors|0-14|Incidence|  6.8|  6.2|  7.6|385|55859601|33
2001|VIII Malignant bone tumors|0-19|Incidence|  9.3|  8.6| 10.0|695|74580361|33
2001|VIII(a) Osteosarcomas|0-14|Incidence|  3.7|  3.2|  4.3|210|55859601|34
2001|VIII(a) Osteosarcomas|0-19|Incidence|  5.1|  4.6|  5.6|380|74580361|34
2001|VIII(b) Chondrosarcomas|0-14|Incidence|~|~|~|~|55859601|35
2001|VIII(b) Chondrosarcomas|0-19|Incidence|  0.3|  0.2|  0.5|26|74580361|35
2001|VIII(c) Ewing tumor and related sarcomas of bone|0-14|Incidence|  2.7|  2.3|  3.1|150|55859601|36
2001|VIII(c) Ewing tumor and related sarcomas of bone|0-19|Incidence|  3.3|  2.9|  3.8|249|74580361|36
2001|VIII(d) Other specified malignant bone tumors|0-14|Incidence|~|~|~|~|55859601|37
2001|VIII(d) Other specified malignant bone tumors|0-19|Incidence|  0.4|  0.3|  0.6|30|74580361|37
2001|VIII(e) Unspecified malignant bone tumors|0-14|Incidence|~|~|~|~|55859601|38
2001|VIII(e) Unspecified malignant bone tumors|0-19|Incidence|~|~|~|~|74580361|38
2001|IX Soft tissue and other extraosseous sarcomas|0-14|Incidence| 10.5|  9.6| 11.4|586|55859601|39
2001|IX Soft tissue and other extraosseous sarcomas|0-19|Incidence| 11.8| 11.0| 12.6|881|74580361|39
2001|IX(a) Rhabdomyosarcomas|0-14|Incidence|  5.2|  4.6|  5.8|289|55859601|40
2001|IX(a) Rhabdomyosarcomas|0-19|Incidence|  5.0|  4.5|  5.6|373|74580361|40
2001|IX(b) Fibrosarcomas, peripheral nerve & other fibrous|0-14|Incidence|  1.2|  1.0|  1.6|70|55859601|41
2001|IX(b) Fibrosarcomas, peripheral nerve & other fibrous|0-19|Incidence|  1.4|  1.2|  1.7|107|74580361|41
2001|IX(c) Kaposi sarcoma|0-14|Incidence|~|~|~|~|55859601|42
2001|IX(c) Kaposi sarcoma|0-19|Incidence|~|~|~|~|74580361|42
2001|IX(d) Other specified soft tissue sarcomas|0-14|Incidence|  3.0|  2.6|  3.5|170|55859601|43
2001|IX(d) Other specified soft tissue sarcomas|0-19|Incidence|  4.1|  3.6|  4.5|304|74580361|43
2001|IX(e) Unspecified soft tissue sarcomas|0-14|Incidence|  1.0|  0.8|  1.3|57|55859601|44
2001|IX(e) Unspecified soft tissue sarcomas|0-19|Incidence|  1.3|  1.0|  1.5|94|74580361|44
2001|X Germ cell & trophoblastic tumors & neoplasms of gonads|0-14|Incidence|  5.1|  4.5|  5.7|287|55859601|45
2001|X Germ cell & trophoblastic tumors & neoplasms of gonads|0-19|Incidence| 10.5|  9.8| 11.3|785|74580361|45
2001|X(a) Intracranial & intraspinal germ cell tumors|0-14|Incidence|  1.3|  1.0|  1.6|73|55859601|46
2001|X(a) Intracranial & intraspinal germ cell tumors|0-19|Incidence|  1.6|  1.3|  1.9|120|74580361|46
2001|X(b) Extracranial & extragonadal germ cell tumors|0-14|Incidence|  1.4|  1.1|  1.8|80|55859601|47
2001|X(b) Extracranial & extragonadal germ cell tumors|0-19|Incidence|  1.6|  1.4|  1.9|123|74580361|47
2001|X(c) Malignant gonadal germ cell tumors|0-14|Incidence|  2.0|  1.7|  2.5|115|55859601|48
2001|X(c) Malignant gonadal germ cell tumors|0-19|Incidence|  6.6|  6.1|  7.2|495|74580361|48
2001|X(d) Gonadal carcinomas|0-14|Incidence|~|~|~|~|55859601|49
2001|X(d) Gonadal carcinomas|0-19|Incidence|  0.3|  0.2|  0.5|26|74580361|49
2001|X(e) Other and unspecified malignant gonadal tumors|0-14|Incidence|~|~|~|~|55859601|50
2001|X(e) Other and unspecified malignant gonadal tumors|0-19|Incidence|  0.3|  0.2|  0.4|21|74580361|50
2001|XI Other malignant epithelial neoplasms and melanomas|0-14|Incidence|  6.9|  6.2|  7.6|387|55859601|51
2001|XI Other malignant epithelial neoplasms and melanomas|0-19|Incidence| 16.5| 15.6| 17.4|1230|74580361|51
2001|XI(a) Adrenocortical carcinomas|0-14|Incidence|~|~|~|~|55859601|52
2001|XI(a) Adrenocortical carcinomas|0-19|Incidence|  0.2|  0.1|  0.3|16|74580361|52
2001|XI(b) Thyroid carcinomas|0-14|Incidence|  2.4|  2.0|  2.9|136|55859601|53
2001|XI(b) Thyroid carcinomas|0-19|Incidence|  5.8|  5.2|  6.3|431|74580361|53
2001|XI(c) Nasopharyngeal carcinomas|0-14|Incidence|  0.3|  0.2|  0.5|19|55859601|54
2001|XI(c) Nasopharyngeal carcinomas|0-19|Incidence|  0.6|  0.4|  0.8|43|74580361|54
2001|XI(d) Malignant melanomas|0-14|Incidence|  2.0|  1.6|  2.4|112|55859601|55
2001|XI(d) Malignant melanomas|0-19|Incidence|  5.7|  5.2|  6.3|429|74580361|55
2001|XI(e) Skin carcinomas|0-14|Incidence|~|~|~|~|55859601|56
2001|XI(e) Skin carcinomas|0-19|Incidence|~|~|~|~|74580361|56
2001|XI(f) Other and unspecified carcinomas|0-14|Incidence|  1.8|  1.5|  2.2|102|55859601|57
2001|XI(f) Other and unspecified carcinomas|0-19|Incidence|  4.1|  3.7|  4.6|307|74580361|57
2001|XII Other and unspecified malignant neoplasms|0-14|Incidence|  0.6|  0.4|  0.8|31|55859601|58
2001|XII Other and unspecified malignant neoplasms|0-19|Incidence|  0.7|  0.5|  0.9|50|74580361|58
2001|XII(a) Other specified malignant tumors|0-14|Incidence|  0.4|  0.2|  0.6|21|55859601|59
2001|XII(a) Other specified malignant tumors|0-19|Incidence|  0.4|  0.2|  0.5|28|74580361|59
2001|XII(b) Other unspecified malignant tumors|0-14|Incidence|~|~|~|~|55859601|60
2001|XII(b) Other unspecified malignant tumors|0-19|Incidence|  0.3|  0.2|  0.4|22|74580361|60
2001|Not classified by ICCC|0-14|Incidence|  0.4|  0.2|  0.6|22|55859601|61
2001|Not classified by ICCC|0-19|Incidence|  0.4|  0.2|  0.5|28|74580361|61
2002|All ICCC Groups Combined |0-14|Incidence|151.8|148.6|155.1|8527|56108821|1
2002|All ICCC Groups Combined |0-19|Incidence|166.9|164.0|169.9|12511|74928432|1
2002|I Leukemias, myeloproliferative & myelodysplastic diseases|0-14|Incidence| 48.7| 46.9| 50.6|2726|56108821|2
2002|I Leukemias, myeloproliferative & myelodysplastic diseases|0-19|Incidence| 44.2| 42.8| 45.8|3309|74928432|2
2002|I(a) Lymphoid leukemias|0-14|Incidence| 36.4| 34.8| 38.0|2033|56108821|3
2002|I(a) Lymphoid leukemias|0-19|Incidence| 31.4| 30.2| 32.7|2345|74928432|3
2002|I(b) Acute myeloid leukemias|0-14|Incidence|  7.9|  7.1|  8.6|443|56108821|4
2002|I(b) Acute myeloid leukemias|0-19|Incidence|  8.2|  7.5|  8.8|613|74928432|4
2002|I(c) Chronic myeloproliferative diseases|0-14|Incidence|  1.4|  1.2|  1.8|82|56108821|5
2002|I(c) Chronic myeloproliferative diseases|0-19|Incidence|  1.9|  1.6|  2.2|141|74928432|5
2002|I(d) Myelodysplastic syndrome and other myeloproliferative|0-14|Incidence|  1.6|  1.3|  2.0|90|56108821|6
2002|I(d) Myelodysplastic syndrome and other myeloproliferative|0-19|Incidence|  1.5|  1.2|  1.8|112|74928432|6
2002|I(e) Unspecified and other specified leukemias|0-14|Incidence|  1.4|  1.1|  1.7|78|56108821|7
2002|I(e) Unspecified and other specified leukemias|0-19|Incidence|  1.3|  1.1|  1.6|98|74928432|7
2002|II Lymphomas and reticuloendothelial neoplasms|0-14|Incidence| 15.5| 14.5| 16.6|874|56108821|8
2002|II Lymphomas and reticuloendothelial neoplasms|0-19|Incidence| 24.1| 23.0| 25.3|1811|74928432|8
2002|II(a) Hodgkin lymphomas|0-14|Incidence|  5.3|  4.7|  5.9|300|56108821|9
2002|II(a) Hodgkin lymphomas|0-19|Incidence| 12.0| 11.2| 12.8|903|74928432|9
2002|II(b) Non-Hodgkin lymphomas (except Burkitt lymphoma)|0-14|Incidence|  6.2|  5.6|  6.9|350|56108821|10
2002|II(b) Non-Hodgkin lymphomas (except Burkitt lymphoma)|0-19|Incidence|  8.3|  7.6|  8.9|620|74928432|10
2002|II(c) Burkitt lymphoma|0-14|Incidence|  2.8|  2.3|  3.2|155|56108821|11
2002|II(c) Burkitt lymphoma|0-19|Incidence|  2.8|  2.4|  3.2|206|74928432|11
2002|II(d) Miscellaneous lymphoreticular neoplasms|0-14|Incidence|  1.0|  0.8|  1.3|57|56108821|12
2002|II(d) Miscellaneous lymphoreticular neoplasms|0-19|Incidence|  0.8|  0.6|  1.0|58|74928432|12
2002|II(e) Unspecified lymphomas|0-14|Incidence|~|~|~|~|56108821|13
2002|II(e) Unspecified lymphomas|0-19|Incidence|  0.3|  0.2|  0.5|24|74928432|13
2002|III CNS and misc intracranial and intraspinal neoplasms|0-14|Incidence| 33.0| 31.5| 34.5|1844|56108821|14
2002|III CNS and misc intracranial and intraspinal neoplasms|0-19|Incidence| 30.0| 28.8| 31.3|2243|74928432|14
2002|III(a) Ependymomas and choroid plexus tumor|0-14|Incidence|  3.6|  3.2|  4.2|204|56108821|15
2002|III(a) Ependymomas and choroid plexus tumor|0-19|Incidence|  3.0|  2.6|  3.4|224|74928432|15
2002|III(b) Astrocytomas|0-14|Incidence| 15.3| 14.3| 16.3|856|56108821|16
2002|III(b) Astrocytomas|0-19|Incidence| 14.4| 13.5| 15.2|1074|74928432|16
2002|III(c) Intracranial and intraspinal embryonal tumors|0-14|Incidence|  7.3|  6.6|  8.1|410|56108821|17
2002|III(c) Intracranial and intraspinal embryonal tumors|0-19|Incidence|  6.3|  5.8|  6.9|472|74928432|17
2002|III(d) Other gliomas|0-14|Incidence|  5.6|  5.0|  6.2|311|56108821|18
2002|III(d) Other gliomas|0-19|Incidence|  5.2|  4.7|  5.7|388|74928432|18
2002|III(e) Other specified intracranial/intraspinal neoplasms|0-14|Incidence|  0.7|  0.5|  1.0|42|56108821|19
2002|III(e) Other specified intracranial/intraspinal neoplasms|0-19|Incidence|  0.7|  0.6|  1.0|56|74928432|19
2002|III(f) Unspecified intracranial and intraspinal neoplasms|0-14|Incidence|  0.4|  0.2|  0.6|21|56108821|20
2002|III(f) Unspecified intracranial and intraspinal neoplasms|0-19|Incidence|  0.4|  0.3|  0.6|29|74928432|20
2002|IV Neuroblastoma and other peripheral nervous cell tumors|0-14|Incidence| 10.6|  9.7| 11.4|595|56108821|21
2002|IV Neuroblastoma and other peripheral nervous cell tumors|0-19|Incidence|  8.1|  7.5|  8.8|611|74928432|21
2002|IV(a) Neuroblastoma and ganglioneuroblastoma|0-14|Incidence| 10.5|  9.7| 11.4|591|56108821|22
2002|IV(a) Neuroblastoma and ganglioneuroblastoma|0-19|Incidence|  7.9|  7.3|  8.6|597|74928432|22
2002|IV(b) Other peripheral nervous cell tumors|0-14|Incidence|~|~|~|~|56108821|23
2002|IV(b) Other peripheral nervous cell tumors|0-19|Incidence|~|~|~|~|74928432|23
2002|V Retinoblastoma|0-14|Incidence|  3.7|  3.3|  4.3|211|56108821|24
2002|V Retinoblastoma|0-19|Incidence|  2.8|  2.4|  3.2|211|74928432|24
2002|VI Renal tumors|0-14|Incidence|  8.2|  7.4|  8.9|456|56108821|25
2002|VI Renal tumors|0-19|Incidence|  6.4|  5.8|  7.0|476|74928432|25
2002|VI(a) Nephroblastoma and other nonepithelial renal tumors|0-14|Incidence|  8.0|  7.2|  8.7|445|56108821|26
2002|VI(a) Nephroblastoma and other nonepithelial renal tumors|0-19|Incidence|  6.0|  5.5|  6.6|448|74928432|26
2002|VI(b) Renal carcinomas|0-14|Incidence|~|~|~|~|56108821|27
2002|VI(b) Renal carcinomas|0-19|Incidence|  0.4|  0.2|  0.5|27|74928432|27
2002|VI(c) Unspecified malignant renal tumors|0-14|Incidence|~|~|~|~|56108821|28
2002|VI(c) Unspecified malignant renal tumors|0-19|Incidence|~|~|~|~|74928432|28
2002|VII Hepatic tumors|0-14|Incidence|  2.0|  1.6|  2.4|110|56108821|29
2002|VII Hepatic tumors|0-19|Incidence|  1.7|  1.4|  2.0|128|74928432|29
2002|VII(a) Hepatoblastoma|0-14|Incidence|  1.6|  1.3|  2.0|90|56108821|30
2002|VII(a) Hepatoblastoma|0-19|Incidence|  1.2|  1.0|  1.5|91|74928432|30
2002|VII(b) Hepatic carcinomas|0-14|Incidence|  0.3|  0.2|  0.5|19|56108821|31
2002|VII(b) Hepatic carcinomas|0-19|Incidence|  0.5|  0.3|  0.7|36|74928432|31
2002|VII(c) Unspecified malignant hepatic tumors|0-14|Incidence|~|~|~|~|56108821|32
2002|VII(c) Unspecified malignant hepatic tumors|0-19|Incidence|~|~|~|~|74928432|32
2002|VIII Malignant bone tumors|0-14|Incidence|  6.7|  6.1|  7.5|381|56108821|33
2002|VIII Malignant bone tumors|0-19|Incidence|  8.9|  8.3|  9.6|671|74928432|33
2002|VIII(a) Osteosarcomas|0-14|Incidence|  3.7|  3.2|  4.2|208|56108821|34
2002|VIII(a) Osteosarcomas|0-19|Incidence|  4.8|  4.4|  5.4|365|74928432|34
2002|VIII(b) Chondrosarcomas|0-14|Incidence|~|~|~|~|56108821|35
2002|VIII(b) Chondrosarcomas|0-19|Incidence|  0.5|  0.3|  0.7|36|74928432|35
2002|VIII(c) Ewing tumor and related sarcomas of bone|0-14|Incidence|  2.5|  2.1|  3.0|143|56108821|36
2002|VIII(c) Ewing tumor and related sarcomas of bone|0-19|Incidence|  3.0|  2.6|  3.4|226|74928432|36
2002|VIII(d) Other specified malignant bone tumors|0-14|Incidence|  0.3|  0.2|  0.5|16|56108821|37
2002|VIII(d) Other specified malignant bone tumors|0-19|Incidence|  0.4|  0.3|  0.6|32|74928432|37
2002|VIII(e) Unspecified malignant bone tumors|0-14|Incidence|~|~|~|~|56108821|38
2002|VIII(e) Unspecified malignant bone tumors|0-19|Incidence|~|~|~|~|74928432|38
2002|IX Soft tissue and other extraosseous sarcomas|0-14|Incidence| 10.8| 10.0| 11.7|609|56108821|39
2002|IX Soft tissue and other extraosseous sarcomas|0-19|Incidence| 11.7| 11.0| 12.5|879|74928432|39
2002|IX(a) Rhabdomyosarcomas|0-14|Incidence|  5.5|  4.9|  6.1|305|56108821|40
2002|IX(a) Rhabdomyosarcomas|0-19|Incidence|  4.9|  4.5|  5.5|370|74928432|40
2002|IX(b) Fibrosarcomas, peripheral nerve & other fibrous|0-14|Incidence|  1.1|  0.9|  1.4|64|56108821|41
2002|IX(b) Fibrosarcomas, peripheral nerve & other fibrous|0-19|Incidence|  1.1|  0.9|  1.4|86|74928432|41
2002|IX(c) Kaposi sarcoma|0-14|Incidence|~|~|~|~|56108821|42
2002|IX(c) Kaposi sarcoma|0-19|Incidence|~|~|~|~|74928432|42
2002|IX(d) Other specified soft tissue sarcomas|0-14|Incidence|  3.3|  2.8|  3.8|186|56108821|43
2002|IX(d) Other specified soft tissue sarcomas|0-19|Incidence|  4.6|  4.1|  5.1|347|74928432|43
2002|IX(e) Unspecified soft tissue sarcomas|0-14|Incidence|  1.0|  0.7|  1.2|54|56108821|44
2002|IX(e) Unspecified soft tissue sarcomas|0-19|Incidence|  1.0|  0.8|  1.3|76|74928432|44
2002|X Germ cell & trophoblastic tumors & neoplasms of gonads|0-14|Incidence|  5.4|  4.8|  6.0|305|56108821|45
2002|X Germ cell & trophoblastic tumors & neoplasms of gonads|0-19|Incidence| 11.0| 10.3| 11.8|827|74928432|45
2002|X(a) Intracranial & intraspinal germ cell tumors|0-14|Incidence|  1.4|  1.1|  1.8|81|56108821|46
2002|X(a) Intracranial & intraspinal germ cell tumors|0-19|Incidence|  1.6|  1.3|  1.9|121|74928432|46
2002|X(b) Extracranial & extragonadal germ cell tumors|0-14|Incidence|  1.5|  1.2|  1.8|83|56108821|47
2002|X(b) Extracranial & extragonadal germ cell tumors|0-19|Incidence|  1.5|  1.3|  1.9|117|74928432|47
2002|X(c) Malignant gonadal germ cell tumors|0-14|Incidence|  2.3|  1.9|  2.8|132|56108821|48
2002|X(c) Malignant gonadal germ cell tumors|0-19|Incidence|  7.3|  6.7|  7.9|545|74928432|48
2002|X(d) Gonadal carcinomas|0-14|Incidence|~|~|~|~|56108821|49
2002|X(d) Gonadal carcinomas|0-19|Incidence|  0.3|  0.2|  0.5|23|74928432|49
2002|X(e) Other and unspecified malignant gonadal tumors|0-14|Incidence|~|~|~|~|56108821|50
2002|X(e) Other and unspecified malignant gonadal tumors|0-19|Incidence|  0.3|  0.2|  0.4|21|74928432|50
2002|XI Other malignant epithelial neoplasms and melanomas|0-14|Incidence|  6.3|  5.7|  7.0|359|56108821|51
2002|XI Other malignant epithelial neoplasms and melanomas|0-19|Incidence| 16.8| 15.9| 17.7|1259|74928432|51
2002|XI(a) Adrenocortical carcinomas|0-14|Incidence|~|~|~|~|56108821|52
2002|XI(a) Adrenocortical carcinomas|0-19|Incidence|  0.3|  0.2|  0.4|19|74928432|52
2002|XI(b) Thyroid carcinomas|0-14|Incidence|  1.7|  1.4|  2.1|99|56108821|53
2002|XI(b) Thyroid carcinomas|0-19|Incidence|  5.5|  5.0|  6.0|411|74928432|53
2002|XI(c) Nasopharyngeal carcinomas|0-14|Incidence|~|~|~|~|56108821|54
2002|XI(c) Nasopharyngeal carcinomas|0-19|Incidence|  0.6|  0.5|  0.8|48|74928432|54
2002|XI(d) Malignant melanomas|0-14|Incidence|  2.2|  1.8|  2.6|124|56108821|55
2002|XI(d) Malignant melanomas|0-19|Incidence|  6.2|  5.7|  6.8|468|74928432|55
2002|XI(e) Skin carcinomas|0-14|Incidence|~|~|~|~|56108821|56
2002|XI(e) Skin carcinomas|0-19|Incidence|~|~|~|~|74928432|56
2002|XI(f) Other and unspecified carcinomas|0-14|Incidence|  1.8|  1.5|  2.2|102|56108821|57
2002|XI(f) Other and unspecified carcinomas|0-19|Incidence|  4.1|  3.6|  4.5|305|74928432|57
2002|XII Other and unspecified malignant neoplasms|0-14|Incidence|  0.6|  0.4|  0.8|34|56108821|58
2002|XII Other and unspecified malignant neoplasms|0-19|Incidence|  0.8|  0.6|  1.0|59|74928432|58
2002|XII(a) Other specified malignant tumors|0-14|Incidence|  0.4|  0.2|  0.5|20|56108821|59
2002|XII(a) Other specified malignant tumors|0-19|Incidence|  0.5|  0.3|  0.6|34|74928432|59
2002|XII(b) Other unspecified malignant tumors|0-14|Incidence|~|~|~|~|56108821|60
2002|XII(b) Other unspecified malignant tumors|0-19|Incidence|  0.3|  0.2|  0.5|25|74928432|60
2002|Not classified by ICCC|0-14|Incidence|  0.4|  0.3|  0.6|23|56108821|61
2002|Not classified by ICCC|0-19|Incidence|  0.4|  0.2|  0.5|27|74928432|61
2003|All ICCC Groups Combined |0-14|Incidence|146.0|142.9|149.1|8530|58213753|1
2003|All ICCC Groups Combined |0-19|Incidence|161.6|158.8|164.5|12620|77864292|1
2003|I Leukemias, myeloproliferative & myelodysplastic diseases|0-14|Incidence| 45.3| 43.6| 47.0|2634|58213753|2
2003|I Leukemias, myeloproliferative & myelodysplastic diseases|0-19|Incidence| 41.3| 39.9| 42.8|3214|77864292|2
2003|I(a) Lymphoid leukemias|0-14|Incidence| 34.3| 32.8| 35.9|1992|58213753|3
2003|I(a) Lymphoid leukemias|0-19|Incidence| 29.4| 28.2| 30.6|2281|77864292|3
2003|I(b) Acute myeloid leukemias|0-14|Incidence|  7.1|  6.5|  7.9|418|58213753|4
2003|I(b) Acute myeloid leukemias|0-19|Incidence|  7.5|  6.9|  8.1|584|77864292|4
2003|I(c) Chronic myeloproliferative diseases|0-14|Incidence|  1.2|  0.9|  1.5|71|58213753|5
2003|I(c) Chronic myeloproliferative diseases|0-19|Incidence|  1.9|  1.6|  2.3|151|77864292|5
2003|I(d) Myelodysplastic syndrome and other myeloproliferative|0-14|Incidence|  1.6|  1.3|  1.9|92|58213753|6
2003|I(d) Myelodysplastic syndrome and other myeloproliferative|0-19|Incidence|  1.4|  1.2|  1.7|112|77864292|6
2003|I(e) Unspecified and other specified leukemias|0-14|Incidence|  1.0|  0.8|  1.3|61|58213753|7
2003|I(e) Unspecified and other specified leukemias|0-19|Incidence|  1.1|  0.9|  1.4|86|77864292|7
2003|II Lymphomas and reticuloendothelial neoplasms|0-14|Incidence| 15.5| 14.5| 16.5|904|58213753|8
2003|II Lymphomas and reticuloendothelial neoplasms|0-19|Incidence| 23.5| 22.5| 24.7|1839|77864292|8
2003|II(a) Hodgkin lymphomas|0-14|Incidence|  5.7|  5.1|  6.4|336|58213753|9
2003|II(a) Hodgkin lymphomas|0-19|Incidence| 12.2| 11.5| 13.0|958|77864292|9
2003|II(b) Non-Hodgkin lymphomas (except Burkitt lymphoma)|0-14|Incidence|  6.2|  5.5|  6.8|360|58213753|10
2003|II(b) Non-Hodgkin lymphomas (except Burkitt lymphoma)|0-19|Incidence|  7.9|  7.3|  8.5|614|77864292|10
2003|II(c) Burkitt lymphoma|0-14|Incidence|  2.6|  2.2|  3.0|148|58213753|11
2003|II(c) Burkitt lymphoma|0-19|Incidence|  2.5|  2.2|  2.9|196|77864292|11
2003|II(d) Miscellaneous lymphoreticular neoplasms|0-14|Incidence|  0.9|  0.6|  1.1|50|58213753|12
2003|II(d) Miscellaneous lymphoreticular neoplasms|0-19|Incidence|  0.7|  0.5|  0.9|53|77864292|12
2003|II(e) Unspecified lymphomas|0-14|Incidence|~|~|~|~|58213753|13
2003|II(e) Unspecified lymphomas|0-19|Incidence|  0.2|  0.1|  0.4|18|77864292|13
2003|III CNS and misc intracranial and intraspinal neoplasms|0-14|Incidence| 30.6| 29.2| 32.1|1781|58213753|14
2003|III CNS and misc intracranial and intraspinal neoplasms|0-19|Incidence| 28.0| 26.8| 29.2|2178|77864292|14
2003|III(a) Ependymomas and choroid plexus tumor|0-14|Incidence|  2.4|  2.0|  2.8|139|58213753|15
2003|III(a) Ependymomas and choroid plexus tumor|0-19|Incidence|  2.2|  1.9|  2.6|174|77864292|15
2003|III(b) Astrocytomas|0-14|Incidence| 15.0| 14.0| 16.0|870|58213753|16
2003|III(b) Astrocytomas|0-19|Incidence| 14.0| 13.2| 14.9|1092|77864292|16
2003|III(c) Intracranial and intraspinal embryonal tumors|0-14|Incidence|  7.0|  6.3|  7.7|406|58213753|17
2003|III(c) Intracranial and intraspinal embryonal tumors|0-19|Incidence|  6.0|  5.4|  6.6|464|77864292|17
2003|III(d) Other gliomas|0-14|Incidence|  5.2|  4.6|  5.8|302|58213753|18
2003|III(d) Other gliomas|0-19|Incidence|  4.7|  4.3|  5.2|368|77864292|18
2003|III(e) Other specified intracranial/intraspinal neoplasms|0-14|Incidence|  0.7|  0.5|  1.0|43|58213753|19
2003|III(e) Other specified intracranial/intraspinal neoplasms|0-19|Incidence|  0.7|  0.5|  0.9|51|77864292|19
2003|III(f) Unspecified intracranial and intraspinal neoplasms|0-14|Incidence|  0.4|  0.2|  0.5|21|58213753|20
2003|III(f) Unspecified intracranial and intraspinal neoplasms|0-19|Incidence|  0.4|  0.2|  0.5|29|77864292|20
2003|IV Neuroblastoma and other peripheral nervous cell tumors|0-14|Incidence| 10.5|  9.7| 11.3|616|58213753|21
2003|IV Neuroblastoma and other peripheral nervous cell tumors|0-19|Incidence|  8.0|  7.4|  8.7|630|77864292|21
2003|IV(a) Neuroblastoma and ganglioneuroblastoma|0-14|Incidence| 10.3|  9.5| 11.2|608|58213753|22
2003|IV(a) Neuroblastoma and ganglioneuroblastoma|0-19|Incidence|  7.9|  7.2|  8.5|618|77864292|22
2003|IV(b) Other peripheral nervous cell tumors|0-14|Incidence|~|~|~|~|58213753|23
2003|IV(b) Other peripheral nervous cell tumors|0-19|Incidence|~|~|~|~|77864292|23
2003|V Retinoblastoma|0-14|Incidence|  3.7|  3.3|  4.3|221|58213753|24
2003|V Retinoblastoma|0-19|Incidence|  2.8|  2.5|  3.2|222|77864292|24
2003|VI Renal tumors|0-14|Incidence|  8.6|  7.8|  9.4|499|58213753|25
2003|VI Renal tumors|0-19|Incidence|  6.7|  6.1|  7.3|521|77864292|25
2003|VI(a) Nephroblastoma and other nonepithelial renal tumors|0-14|Incidence|  8.1|  7.4|  8.9|474|58213753|26
2003|VI(a) Nephroblastoma and other nonepithelial renal tumors|0-19|Incidence|  6.1|  5.6|  6.7|477|77864292|26
2003|VI(b) Renal carcinomas|0-14|Incidence|  0.4|  0.2|  0.5|21|58213753|27
2003|VI(b) Renal carcinomas|0-19|Incidence|  0.5|  0.4|  0.7|40|77864292|27
2003|VI(c) Unspecified malignant renal tumors|0-14|Incidence|~|~|~|~|58213753|28
2003|VI(c) Unspecified malignant renal tumors|0-19|Incidence|~|~|~|~|77864292|28
2003|VII Hepatic tumors|0-14|Incidence|  2.5|  2.1|  3.0|149|58213753|29
2003|VII Hepatic tumors|0-19|Incidence|  2.2|  1.9|  2.6|174|77864292|29
2003|VII(a) Hepatoblastoma|0-14|Incidence|  2.0|  1.7|  2.4|119|58213753|30
2003|VII(a) Hepatoblastoma|0-19|Incidence|  1.5|  1.2|  1.8|119|77864292|30
2003|VII(b) Hepatic carcinomas|0-14|Incidence|  0.5|  0.3|  0.7|29|58213753|31
2003|VII(b) Hepatic carcinomas|0-19|Incidence|  0.7|  0.5|  0.9|53|77864292|31
2003|VII(c) Unspecified malignant hepatic tumors|0-14|Incidence|~|~|~|~|58213753|32
2003|VII(c) Unspecified malignant hepatic tumors|0-19|Incidence|~|~|~|~|77864292|32
2003|VIII Malignant bone tumors|0-14|Incidence|  6.5|  5.8|  7.2|381|58213753|33
2003|VIII Malignant bone tumors|0-19|Incidence|  8.3|  7.7|  9.0|654|77864292|33
2003|VIII(a) Osteosarcomas|0-14|Incidence|  3.7|  3.2|  4.2|216|58213753|34
2003|VIII(a) Osteosarcomas|0-19|Incidence|  5.1|  4.7|  5.7|404|77864292|34
2003|VIII(b) Chondrosarcomas|0-14|Incidence|~|~|~|~|58213753|35
2003|VIII(b) Chondrosarcomas|0-19|Incidence|  0.2|  0.1|  0.4|18|77864292|35
2003|VIII(c) Ewing tumor and related sarcomas of bone|0-14|Incidence|  2.1|  1.8|  2.5|125|58213753|36
2003|VIII(c) Ewing tumor and related sarcomas of bone|0-19|Incidence|  2.5|  2.1|  2.8|192|77864292|36
2003|VIII(d) Other specified malignant bone tumors|0-14|Incidence|~|~|~|~|58213753|37
2003|VIII(d) Other specified malignant bone tumors|0-19|Incidence|  0.3|  0.2|  0.5|24|77864292|37
2003|VIII(e) Unspecified malignant bone tumors|0-14|Incidence|~|~|~|~|58213753|38
2003|VIII(e) Unspecified malignant bone tumors|0-19|Incidence|  0.2|  0.1|  0.3|16|77864292|38
2003|IX Soft tissue and other extraosseous sarcomas|0-14|Incidence| 10.5|  9.7| 11.4|615|58213753|39
2003|IX Soft tissue and other extraosseous sarcomas|0-19|Incidence| 12.0| 11.2| 12.8|938|77864292|39
2003|IX(a) Rhabdomyosarcomas|0-14|Incidence|  5.1|  4.6|  5.8|299|58213753|40
2003|IX(a) Rhabdomyosarcomas|0-19|Incidence|  4.9|  4.4|  5.4|378|77864292|40
2003|IX(b) Fibrosarcomas, peripheral nerve & other fibrous|0-14|Incidence|  1.0|  0.7|  1.3|57|58213753|41
2003|IX(b) Fibrosarcomas, peripheral nerve & other fibrous|0-19|Incidence|  1.3|  1.1|  1.6|104|77864292|41
2003|IX(c) Kaposi sarcoma|0-14|Incidence|~|~|~|~|58213753|42
2003|IX(c) Kaposi sarcoma|0-19|Incidence|~|~|~|~|77864292|42
2003|IX(d) Other specified soft tissue sarcomas|0-14|Incidence|  3.4|  2.9|  3.9|200|58213753|43
2003|IX(d) Other specified soft tissue sarcomas|0-19|Incidence|  4.6|  4.1|  5.1|357|77864292|43
2003|IX(e) Unspecified soft tissue sarcomas|0-14|Incidence|  1.0|  0.7|  1.2|57|58213753|44
2003|IX(e) Unspecified soft tissue sarcomas|0-19|Incidence|  1.2|  1.0|  1.5|96|77864292|44
2003|X Germ cell & trophoblastic tumors & neoplasms of gonads|0-14|Incidence|  4.9|  4.3|  5.5|289|58213753|45
2003|X Germ cell & trophoblastic tumors & neoplasms of gonads|0-19|Incidence| 10.2|  9.5| 11.0|803|77864292|45
2003|X(a) Intracranial & intraspinal germ cell tumors|0-14|Incidence|  1.1|  0.8|  1.4|63|58213753|46
2003|X(a) Intracranial & intraspinal germ cell tumors|0-19|Incidence|  1.3|  1.1|  1.6|105|77864292|46
2003|X(b) Extracranial & extragonadal germ cell tumors|0-14|Incidence|  1.5|  1.2|  1.8|87|58213753|47
2003|X(b) Extracranial & extragonadal germ cell tumors|0-19|Incidence|  1.5|  1.2|  1.8|118|77864292|47
2003|X(c) Malignant gonadal germ cell tumors|0-14|Incidence|  2.1|  1.8|  2.5|125|58213753|48
2003|X(c) Malignant gonadal germ cell tumors|0-19|Incidence|  6.7|  6.1|  7.3|523|77864292|48
2003|X(d) Gonadal carcinomas|0-14|Incidence|~|~|~|~|58213753|49
2003|X(d) Gonadal carcinomas|0-19|Incidence|  0.4|  0.2|  0.5|28|77864292|49
2003|X(e) Other and unspecified malignant gonadal tumors|0-14|Incidence|~|~|~|~|58213753|50
2003|X(e) Other and unspecified malignant gonadal tumors|0-19|Incidence|  0.4|  0.2|  0.5|29|77864292|50
2003|XI Other malignant epithelial neoplasms and melanomas|0-14|Incidence|  6.4|  5.8|  7.1|380|58213753|51
2003|XI Other malignant epithelial neoplasms and melanomas|0-19|Incidence| 17.1| 16.2| 18.1|1342|77864292|51
2003|XI(a) Adrenocortical carcinomas|0-14|Incidence|~|~|~|~|58213753|52
2003|XI(a) Adrenocortical carcinomas|0-19|Incidence|  0.2|  0.1|  0.4|18|77864292|52
2003|XI(b) Thyroid carcinomas|0-14|Incidence|  2.1|  1.8|  2.5|125|58213753|53
2003|XI(b) Thyroid carcinomas|0-19|Incidence|  6.0|  5.4|  6.5|468|77864292|53
2003|XI(c) Nasopharyngeal carcinomas|0-14|Incidence|~|~|~|~|58213753|54
2003|XI(c) Nasopharyngeal carcinomas|0-19|Incidence|  0.7|  0.5|  0.9|52|77864292|54
2003|XI(d) Malignant melanomas|0-14|Incidence|  2.0|  1.7|  2.4|118|58213753|55
2003|XI(d) Malignant melanomas|0-19|Incidence|  5.9|  5.4|  6.5|466|77864292|55
2003|XI(e) Skin carcinomas|0-14|Incidence|~|~|~|~|58213753|56
2003|XI(e) Skin carcinomas|0-19|Incidence|~|~|~|~|77864292|56
2003|XI(f) Other and unspecified carcinomas|0-14|Incidence|  1.9|  1.6|  2.3|112|58213753|57
2003|XI(f) Other and unspecified carcinomas|0-19|Incidence|  4.2|  3.8|  4.7|330|77864292|57
2003|XII Other and unspecified malignant neoplasms|0-14|Incidence|  0.7|  0.5|  1.0|43|58213753|58
2003|XII Other and unspecified malignant neoplasms|0-19|Incidence|  1.0|  0.8|  1.2|78|77864292|58
2003|XII(a) Other specified malignant tumors|0-14|Incidence|  0.3|  0.2|  0.5|18|58213753|59
2003|XII(a) Other specified malignant tumors|0-19|Incidence|  0.4|  0.3|  0.6|34|77864292|59
2003|XII(b) Other unspecified malignant tumors|0-14|Incidence|  0.4|  0.3|  0.6|25|58213753|60
2003|XII(b) Other unspecified malignant tumors|0-19|Incidence|  0.6|  0.4|  0.8|44|77864292|60
2003|Not classified by ICCC|0-14|Incidence|  0.3|  0.2|  0.5|18|58213753|61
2003|Not classified by ICCC|0-19|Incidence|  0.3|  0.2|  0.5|27|77864292|61
2001-2003|All ICCC Groups Combined |0-14|Incidence|151.3|149.5|153.2|24885|164219486|1
2001-2003|All ICCC Groups Combined |0-19|Incidence|166.3|164.6|168.0|36525|219447185|1
2001-2003|I Leukemias, myeloproliferative & myelodysplastic diseases|0-14|Incidence| 48.1| 47.0| 49.2|7880|164219486|2
2001-2003|I Leukemias, myeloproliferative & myelodysplastic diseases|0-19|Incidence| 43.7| 42.8| 44.6|9566|219447185|2
2001-2003|I(a) Lymphoid leukemias|0-14|Incidence| 36.4| 35.5| 37.3|5949|164219486|3
2001-2003|I(a) Lymphoid leukemias|0-19|Incidence| 31.2| 30.5| 32.0|6819|219447185|3
2001-2003|I(b) Acute myeloid leukemias|0-14|Incidence|  7.5|  7.1|  8.0|1244|164219486|4
2001-2003|I(b) Acute myeloid leukemias|0-19|Incidence|  7.9|  7.5|  8.3|1735|219447185|4
2001-2003|I(c) Chronic myeloproliferative diseases|0-14|Incidence|  1.4|  1.2|  1.6|231|164219486|5
2001-2003|I(c) Chronic myeloproliferative diseases|0-19|Incidence|  2.0|  1.8|  2.1|431|219447185|5
2001-2003|I(d) Myelodysplastic syndrome and other myeloproliferative|0-14|Incidence|  1.6|  1.4|  1.8|261|164219486|6
2001-2003|I(d) Myelodysplastic syndrome and other myeloproliferative|0-19|Incidence|  1.5|  1.3|  1.6|322|219447185|6
2001-2003|I(e) Unspecified and other specified leukemias|0-14|Incidence|  1.2|  1.0|  1.4|195|164219486|7
2001-2003|I(e) Unspecified and other specified leukemias|0-19|Incidence|  1.2|  1.0|  1.3|259|219447185|7
2001-2003|II Lymphomas and reticuloendothelial neoplasms|0-14|Incidence| 15.6| 15.0| 16.3|2580|164219486|8
2001-2003|II Lymphomas and reticuloendothelial neoplasms|0-19|Incidence| 24.1| 23.5| 24.8|5309|219447185|8
2001-2003|II(a) Hodgkin lymphomas|0-14|Incidence|  5.6|  5.3|  6.0|931|164219486|9
2001-2003|II(a) Hodgkin lymphomas|0-19|Incidence| 12.3| 11.8| 12.8|2706|219447185|9
2001-2003|II(b) Non-Hodgkin lymphomas (except Burkitt lymphoma)|0-14|Incidence|  6.4|  6.0|  6.8|1048|164219486|10
2001-2003|II(b) Non-Hodgkin lymphomas (except Burkitt lymphoma)|0-19|Incidence|  8.4|  8.0|  8.8|1838|219447185|10
2001-2003|II(c) Burkitt lymphoma|0-14|Incidence|  2.5|  2.3|  2.8|416|164219486|11
2001-2003|II(c) Burkitt lymphoma|0-19|Incidence|  2.5|  2.3|  2.7|544|219447185|11
2001-2003|II(d) Miscellaneous lymphoreticular neoplasms|0-14|Incidence|  0.9|  0.8|  1.1|148|164219486|12
2001-2003|II(d) Miscellaneous lymphoreticular neoplasms|0-19|Incidence|  0.7|  0.6|  0.8|153|219447185|12
2001-2003|II(e) Unspecified lymphomas|0-14|Incidence|  0.2|  0.2|  0.3|37|164219486|13
2001-2003|II(e) Unspecified lymphomas|0-19|Incidence|  0.3|  0.2|  0.4|68|219447185|13
2001-2003|III CNS and misc intracranial and intraspinal neoplasms|0-14|Incidence| 32.0| 31.1| 32.8|5237|164219486|14
2001-2003|III CNS and misc intracranial and intraspinal neoplasms|0-19|Incidence| 29.2| 28.5| 29.9|6402|219447185|14
2001-2003|III(a) Ependymomas and choroid plexus tumor|0-14|Incidence|  2.9|  2.6|  3.1|472|164219486|15
2001-2003|III(a) Ependymomas and choroid plexus tumor|0-19|Incidence|  2.5|  2.3|  2.7|550|219447185|15
2001-2003|III(b) Astrocytomas|0-14|Incidence| 15.3| 14.8| 16.0|2515|164219486|16
2001-2003|III(b) Astrocytomas|0-19|Incidence| 14.3| 13.8| 14.9|3143|219447185|16
2001-2003|III(c) Intracranial and intraspinal embryonal tumors|0-14|Incidence|  7.3|  6.9|  7.7|1188|164219486|17
2001-2003|III(c) Intracranial and intraspinal embryonal tumors|0-19|Incidence|  6.3|  6.0|  6.7|1385|219447185|17
2001-2003|III(d) Other gliomas|0-14|Incidence|  5.4|  5.0|  5.8|884|164219486|18
2001-2003|III(d) Other gliomas|0-19|Incidence|  5.0|  4.7|  5.3|1094|219447185|18
2001-2003|III(e) Other specified intracranial/intraspinal neoplasms|0-14|Incidence|  0.7|  0.6|  0.8|116|164219486|19
2001-2003|III(e) Other specified intracranial/intraspinal neoplasms|0-19|Incidence|  0.7|  0.6|  0.8|145|219447185|19
2001-2003|III(f) Unspecified intracranial and intraspinal neoplasms|0-14|Incidence|  0.4|  0.3|  0.5|62|164219486|20
2001-2003|III(f) Unspecified intracranial and intraspinal neoplasms|0-19|Incidence|  0.4|  0.3|  0.5|85|219447185|20
2001-2003|IV Neuroblastoma and other peripheral nervous cell tumors|0-14|Incidence| 10.8| 10.3| 11.3|1786|164219486|21
2001-2003|IV Neuroblastoma and other peripheral nervous cell tumors|0-19|Incidence|  8.3|  7.9|  8.7|1826|219447185|21
2001-2003|IV(a) Neuroblastoma and ganglioneuroblastoma|0-14|Incidence| 10.7| 10.2| 11.2|1769|164219486|22
2001-2003|IV(a) Neuroblastoma and ganglioneuroblastoma|0-19|Incidence|  8.1|  7.7|  8.5|1791|219447185|22
2001-2003|IV(b) Other peripheral nervous cell tumors|0-14|Incidence|  0.1|  0.1|  0.2|17|164219486|23
2001-2003|IV(b) Other peripheral nervous cell tumors|0-19|Incidence|  0.2|  0.1|  0.2|35|219447185|23
2001-2003|V Retinoblastoma|0-14|Incidence|  4.0|  3.7|  4.3|660|164219486|24
2001-2003|V Retinoblastoma|0-19|Incidence|  3.0|  2.8|  3.2|661|219447185|24
2001-2003|VI Renal tumors|0-14|Incidence|  8.5|  8.0|  8.9|1387|164219486|25
2001-2003|VI Renal tumors|0-19|Incidence|  6.6|  6.3|  7.0|1453|219447185|25
2001-2003|VI(a) Nephroblastoma and other nonepithelial renal tumors|0-14|Incidence|  8.1|  7.7|  8.6|1332|164219486|26
2001-2003|VI(a) Nephroblastoma and other nonepithelial renal tumors|0-19|Incidence|  6.1|  5.8|  6.5|1341|219447185|26
2001-2003|VI(b) Renal carcinomas|0-14|Incidence|  0.3|  0.2|  0.4|48|164219486|27
2001-2003|VI(b) Renal carcinomas|0-19|Incidence|  0.5|  0.4|  0.6|105|219447185|27
2001-2003|VI(c) Unspecified malignant renal tumors|0-14|Incidence|~|~|~|~|164219486|28
2001-2003|VI(c) Unspecified malignant renal tumors|0-19|Incidence|~|~|~|~|219447185|28
2001-2003|VII Hepatic tumors|0-14|Incidence|  2.2|  2.0|  2.4|364|164219486|29
2001-2003|VII Hepatic tumors|0-19|Incidence|  1.9|  1.7|  2.1|424|219447185|29
2001-2003|VII(a) Hepatoblastoma|0-14|Incidence|  1.8|  1.6|  2.0|293|164219486|30
2001-2003|VII(a) Hepatoblastoma|0-19|Incidence|  1.3|  1.2|  1.5|295|219447185|30
2001-2003|VII(b) Hepatic carcinomas|0-14|Incidence|  0.4|  0.3|  0.5|68|164219486|31
2001-2003|VII(b) Hepatic carcinomas|0-19|Incidence|  0.6|  0.5|  0.7|125|219447185|31
2001-2003|VII(c) Unspecified malignant hepatic tumors|0-14|Incidence|~|~|~|~|164219486|32
2001-2003|VII(c) Unspecified malignant hepatic tumors|0-19|Incidence|~|~|~|~|219447185|32
2001-2003|VIII Malignant bone tumors|0-14|Incidence|  6.7|  6.3|  7.1|1115|164219486|33
2001-2003|VIII Malignant bone tumors|0-19|Incidence|  8.9|  8.5|  9.3|1965|219447185|33
2001-2003|VIII(a) Osteosarcomas|0-14|Incidence|  3.7|  3.4|  4.0|619|164219486|34
2001-2003|VIII(a) Osteosarcomas|0-19|Incidence|  5.1|  4.8|  5.4|1119|219447185|34
2001-2003|VIII(b) Chondrosarcomas|0-14|Incidence|  0.1|  0.1|  0.2|25|164219486|35
2001-2003|VIII(b) Chondrosarcomas|0-19|Incidence|  0.3|  0.3|  0.4|77|219447185|35
2001-2003|VIII(c) Ewing tumor and related sarcomas of bone|0-14|Incidence|  2.5|  2.2|  2.7|407|164219486|36
2001-2003|VIII(c) Ewing tumor and related sarcomas of bone|0-19|Incidence|  3.0|  2.7|  3.2|651|219447185|36
2001-2003|VIII(d) Other specified malignant bone tumors|0-14|Incidence|  0.2|  0.2|  0.3|41|164219486|37
2001-2003|VIII(d) Other specified malignant bone tumors|0-19|Incidence|  0.4|  0.3|  0.5|84|219447185|37
2001-2003|VIII(e) Unspecified malignant bone tumors|0-14|Incidence|  0.1|  0.1|  0.2|23|164219486|38
2001-2003|VIII(e) Unspecified malignant bone tumors|0-19|Incidence|  0.2|  0.1|  0.2|34|219447185|38
2001-2003|IX Soft tissue and other extraosseous sarcomas|0-14|Incidence| 10.6| 10.1| 11.1|1750|164219486|39
2001-2003|IX Soft tissue and other extraosseous sarcomas|0-19|Incidence| 11.8| 11.4| 12.3|2606|219447185|39
2001-2003|IX(a) Rhabdomyosarcomas|0-14|Incidence|  5.3|  5.0|  5.7|868|164219486|40
2001-2003|IX(a) Rhabdomyosarcomas|0-19|Incidence|  5.0|  4.7|  5.3|1089|219447185|40
2001-2003|IX(b) Fibrosarcomas, peripheral nerve & other fibrous|0-14|Incidence|  1.1|  0.9|  1.3|181|164219486|41
2001-2003|IX(b) Fibrosarcomas, peripheral nerve & other fibrous|0-19|Incidence|  1.3|  1.1|  1.4|283|219447185|41
2001-2003|IX(c) Kaposi sarcoma|0-14|Incidence|~|~|~|~|164219486|42
2001-2003|IX(c) Kaposi sarcoma|0-19|Incidence|~|~|~|~|219447185|42
2001-2003|IX(d) Other specified soft tissue sarcomas|0-14|Incidence|  3.2|  3.0|  3.5|537|164219486|43
2001-2003|IX(d) Other specified soft tissue sarcomas|0-19|Incidence|  4.4|  4.2|  4.7|977|219447185|43
2001-2003|IX(e) Unspecified soft tissue sarcomas|0-14|Incidence|  1.0|  0.8|  1.1|162|164219486|44
2001-2003|IX(e) Unspecified soft tissue sarcomas|0-19|Incidence|  1.1|  1.0|  1.3|251|219447185|44
2001-2003|X Germ cell & trophoblastic tumors & neoplasms of gonads|0-14|Incidence|  5.2|  4.9|  5.6|869|164219486|45
2001-2003|X Germ cell & trophoblastic tumors & neoplasms of gonads|0-19|Incidence| 10.7| 10.3| 11.2|2365|219447185|45
2001-2003|X(a) Intracranial & intraspinal germ cell tumors|0-14|Incidence|  1.3|  1.1|  1.5|212|164219486|46
2001-2003|X(a) Intracranial & intraspinal germ cell tumors|0-19|Incidence|  1.5|  1.4|  1.7|339|219447185|46
2001-2003|X(b) Extracranial & extragonadal germ cell tumors|0-14|Incidence|  1.5|  1.3|  1.7|246|164219486|47
2001-2003|X(b) Extracranial & extragonadal germ cell tumors|0-19|Incidence|  1.6|  1.4|  1.8|351|219447185|47
2001-2003|X(c) Malignant gonadal germ cell tumors|0-14|Incidence|  2.2|  2.0|  2.5|369|164219486|48
2001-2003|X(c) Malignant gonadal germ cell tumors|0-19|Incidence|  6.9|  6.6|  7.3|1528|219447185|48
2001-2003|X(d) Gonadal carcinomas|0-14|Incidence|  0.1|  0.1|  0.2|16|164219486|49
2001-2003|X(d) Gonadal carcinomas|0-19|Incidence|  0.3|  0.3|  0.4|77|219447185|49
2001-2003|X(e) Other and unspecified malignant gonadal tumors|0-14|Incidence|  0.2|  0.1|  0.2|26|164219486|50
2001-2003|X(e) Other and unspecified malignant gonadal tumors|0-19|Incidence|  0.3|  0.2|  0.4|70|219447185|50
2001-2003|XI Other malignant epithelial neoplasms and melanomas|0-14|Incidence|  6.6|  6.2|  7.0|1093|164219486|51
2001-2003|XI Other malignant epithelial neoplasms and melanomas|0-19|Incidence| 16.8| 16.3| 17.4|3701|219447185|51
2001-2003|XI(a) Adrenocortical carcinomas|0-14|Incidence|  0.2|  0.2|  0.3|39|164219486|52
2001-2003|XI(a) Adrenocortical carcinomas|0-19|Incidence|  0.2|  0.2|  0.3|50|219447185|52
2001-2003|XI(b) Thyroid carcinomas|0-14|Incidence|  2.1|  1.9|  2.3|352|164219486|53
2001-2003|XI(b) Thyroid carcinomas|0-19|Incidence|  5.8|  5.5|  6.1|1275|219447185|53
2001-2003|XI(c) Nasopharyngeal carcinomas|0-14|Incidence|  0.3|  0.2|  0.4|44|164219486|54
2001-2003|XI(c) Nasopharyngeal carcinomas|0-19|Incidence|  0.6|  0.5|  0.7|138|219447185|54
2001-2003|XI(d) Malignant melanomas|0-14|Incidence|  2.1|  1.9|  2.3|348|164219486|55
2001-2003|XI(d) Malignant melanomas|0-19|Incidence|  6.0|  5.6|  6.3|1311|219447185|55
2001-2003|XI(e) Skin carcinomas|0-14|Incidence|~|~|~|~|164219486|56
2001-2003|XI(e) Skin carcinomas|0-19|Incidence|  0.1|  0.1|  0.1|20|219447185|56
2001-2003|XI(f) Other and unspecified carcinomas|0-14|Incidence|  1.8|  1.6|  2.0|299|164219486|57
2001-2003|XI(f) Other and unspecified carcinomas|0-19|Incidence|  4.1|  3.9|  4.4|907|219447185|57
2001-2003|XII Other and unspecified malignant neoplasms|0-14|Incidence|  0.6|  0.5|  0.8|104|164219486|58
2001-2003|XII Other and unspecified malignant neoplasms|0-19|Incidence|  0.8|  0.7|  0.9|168|219447185|58
2001-2003|XII(a) Other specified malignant tumors|0-14|Incidence|  0.4|  0.3|  0.5|58|164219486|59
2001-2003|XII(a) Other specified malignant tumors|0-19|Incidence|  0.4|  0.3|  0.5|93|219447185|59
2001-2003|XII(b) Other unspecified malignant tumors|0-14|Incidence|  0.3|  0.2|  0.4|46|164219486|60
2001-2003|XII(b) Other unspecified malignant tumors|0-19|Incidence|  0.3|  0.3|  0.4|75|219447185|60
2001-2003|Not classified by ICCC|0-14|Incidence|  0.4|  0.3|  0.5|60|164219486|61
2001-2003|Not classified by ICCC|0-19|Incidence|  0.4|  0.3|  0.4|79|219447185|61
